$CVRS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Corindus Vascular Robotics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Corindus Vascular Robotics, Inc.. Get notifications about new insider transactions in Corindus Vascular Robotics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 1.40 | 350,000 | 490,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 1.25 | 7,799 | 9,749 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 1.40 | 350,000 | 490,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 1.25 | 40,000 | 50,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 1.25 | 7,799 | 9,749 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 0.97 | 3,607 | 3,500 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 1.25 | 40,000 | 50,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 1.85 | 5,566 | 10,297 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 0.97 | 3,607 | 3,500 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 1.68 | 17,857 | 30,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 1.85 | 5,566 | 10,297 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 1.68 | 5,332 | 8,958 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 1.68 | 17,857 | 30,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Sell | D | 4.28 | 7,557,436 | 32,345,826 | 0 | 7.6 M to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Option Exercise | D | 1.68 | 5,332 | 8,958 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Sell | D | 4.28 | 573,798 | 2,455,855 | 0 | 573.8 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Sell | D | 4.28 | 7,557,436 | 32,345,826 | 0 | 7.6 M to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Sell | D | 4.28 | 303,440 | 1,298,723 | 0 | 303.4 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Sell | D | 4.28 | 573,798 | 2,455,855 | 0 | 573.8 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Sell | D | 4.28 | 303,440 | 1,298,723 | 0 | 303.4 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Sell | D | 4.28 | 106,112 | 454,159 | 0 | 106.1 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Sell | D | 4.28 | 106,112 | 454,159 | 0 | 106.1 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Harrington Nathan R | Director | Option Exercise | D | 1.68 | 17,857 | 30,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Harrington Nathan R | Director | Option Exercise | D | 1.68 | 17,857 | 30,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Harrington Nathan R | Director | Sell | D | 4.28 | 90,149 | 385,838 | 0 | 90.1 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Harrington Nathan R | Director | Sell | D | 4.28 | 90,149 | 385,838 | 0 | 90.1 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Option Exercise | D | 1.68 | 17,857 | 30,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Option Exercise | D | 1.68 | 17,857 | 30,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Option Exercise | D | 1.10 | 27,272 | 29,999 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Option Exercise | D | 1.10 | 27,272 | 29,999 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Option Exercise | D | 2.03 | 98,522 | 200,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Option Exercise | D | 2.03 | 98,522 | 200,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Sell | D | 4.28 | 90,149 | 385,838 | 0 | 90.1 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Sell | D | 4.28 | 90,149 | 385,838 | 0 | 90.1 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 1.68 | 17,857 | 30,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 1.68 | 17,857 | 30,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 1.10 | 27,272 | 29,999 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 1.10 | 27,272 | 29,999 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 1.46 | 35,000 | 51,100 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 1.46 | 35,000 | 51,100 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 4.25 | 68,493 | 291,095 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 4.25 | 68,493 | 291,095 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 0.55 | 25,002 | 13,749 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 0.55 | 25,002 | 13,749 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 0.55 | 25,002 | 13,749 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 0.55 | 25,002 | 13,749 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 0.55 | 57,504 | 31,621 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 0.55 | 57,504 | 31,621 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 0.55 | 25,002 | 13,749 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 0.55 | 25,002 | 13,749 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 0.55 | 50,004 | 27,497 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Option Exercise | D | 0.55 | 50,004 | 27,497 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Sell | D | 4.28 | 115,149 | 492,838 | 0 | 115.1 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Sell | D | 4.28 | 115,149 | 492,838 | 0 | 115.1 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | D | 1.20 | 110,000 | 132,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | D | 1.20 | 110,000 | 132,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | D | 1.05 | 110,000 | 115,500 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | D | 1.05 | 110,000 | 115,500 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | D | 1.17 | 100,000 | 117,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | D | 1.17 | 100,000 | 117,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | D | 1.46 | 100,000 | 146,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | D | 1.46 | 100,000 | 146,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | D | 0.75 | 285,773 | 214,530 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | D | 0.75 | 285,773 | 214,530 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | D | 0.55 | 590,048 | 324,467 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | D | 0.55 | 590,048 | 324,467 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Teany Douglas | Chief Operating Off ... | Option Exercise | D | 1.20 | 250,000 | 300,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Teany Douglas | Chief Operating Off ... | Option Exercise | D | 1.20 | 250,000 | 300,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Teany Douglas | Chief Operating Off ... | Option Exercise | D | 0.89 | 500,000 | 445,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Teany Douglas | Chief Operating Off ... | Option Exercise | D | 0.89 | 500,000 | 445,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Teany Douglas | Chief Operating Off ... | Option Exercise | D | 1.05 | 125,000 | 131,250 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Teany Douglas | Chief Operating Off ... | Option Exercise | D | 1.05 | 125,000 | 131,250 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Teany Douglas | Chief Operating Off ... | Option Exercise | D | 1.17 | 100,000 | 117,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Teany Douglas | Chief Operating Off ... | Option Exercise | D | 1.17 | 100,000 | 117,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Teany Douglas | Chief Operating Off ... | Option Exercise | D | 0.99 | 400,000 | 396,400 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Teany Douglas | Chief Operating Off ... | Option Exercise | D | 0.99 | 400,000 | 396,400 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | D | 0.75 | 5,183,322 | 3,888,010 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | D | 0.75 | 5,183,322 | 3,888,010 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | D | 0.71 | 297,335 | 209,621 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | D | 0.71 | 297,335 | 209,621 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | D | 0.71 | 297,335 | 209,621 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | D | 0.71 | 297,335 | 209,621 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | D | 0.71 | 297,335 | 209,621 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | D | 0.71 | 297,335 | 209,621 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | D | 1.46 | 7,136,049 | 10,418,632 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | D | 1.46 | 7,136,049 | 10,418,632 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | D | 1.46 | 297,335 | 434,109 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Toland Mark J | President and CEO | Option Exercise | D | 1.46 | 297,335 | 434,109 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Option Exercise | D | 1.40 | 4,725,000 | 6,615,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Option Exercise | D | 1.40 | 4,725,000 | 6,615,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Option Exercise | D | 1.25 | 105,281 | 131,601 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Option Exercise | D | 1.25 | 105,281 | 131,601 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Option Exercise | D | 1.25 | 540,000 | 675,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Option Exercise | D | 1.25 | 540,000 | 675,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Sell | D | 4.28 | 14,235,545 | 60,928,133 | 0 | 14.2 M to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Sell | D | 4.28 | 14,235,545 | 60,928,133 | 0 | 14.2 M to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Sell | D | 4.28 | 106,219 | 454,617 | 0 | 106.2 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Sell | D | 4.28 | 106,219 | 454,617 | 0 | 106.2 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Hudson Executive Capital LP | 10% Owner | Option Exercise | D | 1.40 | 4,725,000 | 6,615,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Hudson Executive Capital LP | 10% Owner | Option Exercise | D | 1.25 | 105,281 | 131,601 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Hudson Executive Capital LP | 10% Owner | Option Exercise | D | 1.25 | 540,000 | 675,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | Hudson Executive Capital LP | 10% Owner | Sell | D | 4.28 | 14,235,545 | 60,928,133 | 0 | 14.2 M to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Hudson Executive Capital LP | 10% Owner | Sell | D | 4.28 | 106,219 | 454,617 | 0 | 106.2 K to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | Director | Option Exercise | D | 1.68 | 17,857 | 30,000 | 0 | |
Oct 31 2019 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | Director | Sell | D | 4.28 | 26,449,007 | 113,201,750 | 0 | 26.4 M to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | Director | Grant | A | 2.17 | 27,649 | 59,998 | 26,449,007 | 26.4 M to 26.4 M (+0.10 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | Lightcap Jeffrey C | Director | Sell | J | 4.28 | 32,500,478 | 139,102,046 | 0 | 32.5 M to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | HealthCor Management, L.P. | 10% Owner | Sell | J | 4.28 | 19,981,655 | 85,521,483 | 0 | 20 M to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | HealthCor Management, L.P. | 10% Owner | Sell | J | 4.28 | 15,409,537 | 65,952,818 | 0 | 15.4 M to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | HealthCor Management, L.P. | 10% Owner | Sell | J | 4.28 | 17,090,941 | 73,149,227 | 0 | 17.1 M to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | HealthCor Management, L.P. | 10% Owner | Sell | J | 4.28 | 19,981,655 | 85,521,483 | 0 | 20 M to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | HealthCor Management, L.P. | 10% Owner | Sell | J | 4.28 | 15,409,537 | 65,952,818 | 0 | 15.4 M to 0 (-100.00 %) |
Oct 31 2019 | CVRS | Corindus Vascular ... | HealthCor Management, L.P. | 10% Owner | Sell | J | 4.28 | 17,090,941 | 73,149,227 | 0 | 17.1 M to 0 (-100.00 %) |
Oct 09 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 4.27 | 1,170 | 4,996 | 106,219 | 105 K to 106.2 K (+1.11 %) |
Oct 09 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Grant | A | 4.27 | 1,639 | 6,999 | 303,440 | 301.8 K to 303.4 K (+0.54 %) |
Oct 09 2019 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Grant | A | 4.27 | 1,170 | 4,996 | 106,112 | 104.9 K to 106.1 K (+1.11 %) |
Jul 10 2019 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Grant | A | 3.44 | 1,453 | 4,998 | 104,942 | 103.5 K to 104.9 K (+1.40 %) |
Jul 10 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Grant | A | 3.44 | 2,034 | 6,997 | 301,801 | 299.8 K to 301.8 K (+0.68 %) |
Jul 10 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 3.44 | 1,453 | 4,998 | 105,049 | 103.6 K to 105 K (+1.40 %) |
May 23 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 2.63 | 7,500 | 19,719 | 299,767 | 292.3 K to 299.8 K (+2.57 %) |
May 07 2019 | CVRS | Corindus Vascular ... | Rogers Campbell | Director | Grant | A | 2.17 | 27,649 | 59,998 | 90,149 | 62.5 K to 90.1 K (+44.24 %) |
May 07 2019 | CVRS | Corindus Vascular ... | GOLD JEFFREY | Director | Grant | A | 2.17 | 27,649 | 59,998 | 115,149 | 87.5 K to 115.1 K (+31.60 %) |
May 07 2019 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Grant | A | 2.17 | 27,649 | 59,998 | 103,489 | 75.8 K to 103.5 K (+36.46 %) |
May 07 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 2.17 | 27,649 | 59,998 | 103,596 | 75.9 K to 103.6 K (+36.41 %) |
May 07 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Grant | A | 2.17 | 27,649 | 59,998 | 292,267 | 264.6 K to 292.3 K (+10.45 %) |
May 07 2019 | CVRS | Corindus Vascular ... | Harrington Nathan R | Director | Grant | A | 2.17 | 27,649 | 59,998 | 90,149 | 62.5 K to 90.1 K (+44.24 %) |
Apr 09 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Grant | A | 2.12 | 3,301 | 6,998 | 264,618 | 261.3 K to 264.6 K (+1.26 %) |
Apr 09 2019 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Grant | A | 2.12 | 2,358 | 4,999 | 75,840 | 73.5 K to 75.8 K (+3.21 %) |
Apr 09 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 2.12 | 2,358 | 4,999 | 75,947 | 73.6 K to 75.9 K (+3.20 %) |
Mar 27 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 1.80 | 10,000 | 18,000 | 261,317 | 251.3 K to 261.3 K (+3.98 %) |
Mar 15 2019 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | Director | Option Exercise | A | 1.68 | 17,857 | 30,000 | 17,857 | |
Mar 15 2019 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | Director | Grant | A | 0.75 | 53,326 | 40,000 | 26,421,358 | 26.4 M to 26.4 M (+0.20 %) |
Mar 15 2019 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | Director | Grant | A | 0.00 | 9,174 | 0 | 26,368,032 | 26.4 M to 26.4 M (+0.03 %) |
Mar 15 2019 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | Director | Option Exercise | A | 1.68 | 17,857 | 30,000 | 17,857 | |
Mar 15 2019 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | Director | Grant | A | 0.75 | 53,326 | 40,000 | 26,421,358 | 26.4 M to 26.4 M (+0.20 %) |
Mar 15 2019 | CVRS | Corindus Vascular ... | KONINKLIJKE PHILIPS NV | Director | Grant | A | 0.00 | 9,174 | 0 | 26,368,032 | 26.4 M to 26.4 M (+0.03 %) |
Mar 14 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Buy | P | 1.38 | 2,899,391 | 4,000,000 | 14,235,545 | 11.3 M to 14.2 M (+25.58 %) |
Mar 14 2019 | CVRS | Corindus Vascular ... | Hudson Executive Capital LP | 10% Owner | Buy | P | 1.38 | 2,899,391 | 4,000,000 | 14,235,545 | 11.3 M to 14.2 M (+25.58 %) |
Mar 13 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 1.38 | 573,798 | 791,612 | 573,798 | 0 to 573.8 K |
Feb 05 2019 | CVRS | Corindus Vascular ... | Teany Douglas | Chief Operating Off ... | Option Exercise | A | 1.20 | 250,000 | 300,000 | 250,000 | |
Feb 05 2019 | CVRS | Corindus Vascular ... | Long David W | CFO/Sr VP/Sec./Trea ... | Option Exercise | A | 1.20 | 110,000 | 132,000 | 110,000 | |
Jan 10 2019 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Grant | A | 1.12 | 6,808 | 7,625 | 251,317 | 244.5 K to 251.3 K (+2.78 %) |
Jan 10 2019 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 1.12 | 5,357 | 6,000 | 73,589 | 68.2 K to 73.6 K (+7.85 %) |
Jan 10 2019 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Grant | A | 1.12 | 4,464 | 5,000 | 73,482 | 69 K to 73.5 K (+6.47 %) |
Oct 09 2018 | CVRS | Corindus Vascular ... | TOBIN JAMES R | Director | Grant | A | 1.25 | 3,200 | 4,000 | 69,018 | 65.8 K to 69 K (+4.86 %) |
Oct 09 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Grant | A | 1.25 | 5,600 | 7,000 | 244,509 | 238.9 K to 244.5 K (+2.34 %) |
Oct 09 2018 | CVRS | Corindus Vascular ... | Braunstein Douglas L | Director | Grant | A | 1.25 | 3,200 | 4,000 | 68,232 | 65 K to 68.2 K (+4.92 %) |
Aug 27 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 1.03 | 15,000 | 15,461 | 238,909 | 223.9 K to 238.9 K (+6.70 %) |
Aug 27 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 1.02 | 15,000 | 15,275 | 223,909 | 208.9 K to 223.9 K (+7.18 %) |
Aug 23 2018 | CVRS | Corindus Vascular ... | Cannon Louis A | Director | Buy | P | 0.99 | 15,000 | 14,913 | 0 | -15,000 to 0 (-100.00 %) |